These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 8554943)

  • 1. Lack of effect of a 5-HT3 antagonist, pancopride, on lower oesophageal sphincter pressure in volunteers.
    Grande L; Lacima G; Pérez A; Zayas JM
    Br J Clin Pharmacol; 1995 Oct; 40(4):401-3. PubMed ID: 8554943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A double-blind dose ranging study of BRL 24924 and metoclopramide on lower oesophageal sphincter pressure in healthy volunteers.
    Robertson CS; Ledingham SJ; Cooper SM; Evans DF
    Br J Clin Pharmacol; 1989 Sep; 28(3):323-7. PubMed ID: 2789926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double-blind placebo-controlled trial of BRL 24924 on lower oesophageal sphincter pressure and gastro-oesophageal reflux in healthy volunteers.
    Robertson CS; Evans DF; Hicks F; Atkinson M
    Aliment Pharmacol Ther; 1988 Dec; 2(6):501-6. PubMed ID: 2979272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pancopride, a potent and long-acting 5-HT3 receptor antagonist, is orally effective against anticancer drug-evoked emesis.
    Fernández AG; Puig J; Beleta J; Doménech T; Bou J; Berga P; Gristwood RW; Roberts DJ
    Eur J Pharmacol; 1992 Nov; 222(2-3):257-64. PubMed ID: 1451737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single dose pharmacokinetics and tolerance of pancopride in healthy volunteers.
    Dewland P; Pérez Campos A; Martinez-Tobed A
    Arzneimittelforschung; 1995 Feb; 45(2):177-83. PubMed ID: 7710444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the 5-HT3 receptor antagonist, ICS 205-930, on oesophageal motor activity and on lower oesophageal sphincter pressure: a double-blind cross-over study.
    Stacher G; Steiner G; Guapmann G; Stacher-Janotta G; Schneider C; Steinringer H
    Hepatogastroenterology; 1990 Dec; 37 Suppl 2():118-21. PubMed ID: 2083922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of serotonin3 receptors in the nucleus tractus solitarii on the carotid chemoreflex.
    Sévoz C; Callera JC; Machado BH; Hamon M; Laguzzi R
    Am J Physiol; 1997 Mar; 272(3 Pt 2):H1250-9. PubMed ID: 9087599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution and characterisation of the [3H](S)-zacopride labelled 5-HT3 receptor in pig forebrain.
    Fletcher S; Barnes NM
    Brain Res; 1996 Aug; 729(2):281-4. PubMed ID: 8877001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repeated dose pharmacokinetics of pancopride in human volunteers.
    Salva P; Costa J; Pérez-Campos A; Martínez-Tobed A
    Biopharm Drug Dispos; 1994 Nov; 15(8):643-51. PubMed ID: 7888596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zatosetron, a 5-HT3 receptor antagonist in a multicenter trial for acute migraine.
    Chappell AS; Bay JM; Botzum GD; Cohen ML
    Neuropharmacology; 1994; 33(3-4):509-13. PubMed ID: 7984290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The clinical development of an antiemetic in oncology. A meta-analysis].
    Pérez Campos A
    Med Clin (Barc); 1994 Sep; 103(8):281-6. PubMed ID: 7967877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the 5-HT3 receptor antagonist properties of ICS 205-930, GR38032F and zacopride.
    Cohen ML; Bloomquist W; Gidda JS; Lacefield W
    J Pharmacol Exp Ther; 1989 Jan; 248(1):197-201. PubMed ID: 2521513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological properties of a novel gastrointestinal prokinetic benzamide selective for human 5-HT4 receptor versus human 5-HT3 receptor.
    Nagakura Y; Akuzawa S; Miyata K; Kamato T; Suzuki T; Ito H; Yamaguchi T
    Pharmacol Res; 1999 May; 39(5):375-82. PubMed ID: 10328995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential localization of 5-hydroxytryptamine3 and 5-hydroxytryptamine4 receptors in the human rectum.
    Sakurai-Yamashita Y; Yamashita K; Yoshimura M; Taniyama K
    Life Sci; 2000; 66(1):31-4. PubMed ID: 10658921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of (S)-des-4-amino-3-[125I]iodozacopride ([125I]DAIZAC), a selective high-affinity radioligand for 5-hydroxytryptamine3 receptors.
    Hewlett WA; Trivedi BL; Zhang ZJ; de Paulis T; Schmidt DE; Lovinger DM; Ansari MS; Ebert MH
    J Pharmacol Exp Ther; 1999 Jan; 288(1):221-31. PubMed ID: 9862774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-HT3 receptor agonism may be responsible for the emetic effects of zacopride in the ferret.
    Middlefell VC; Price TL
    Br J Pharmacol; 1991 May; 103(1):1011-2. PubMed ID: 1831684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Role of 5-HT3 receptors in the control by cholecystokinin of transient relaxations of the inferior esophageal sphincter in dogs].
    Rouzade ML; Fioramonti J; Bueno L
    Gastroenterol Clin Biol; 1996; 20(6-7):575-80. PubMed ID: 8881571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Action of serotonin in the medial prefrontal cortex: mediation by serotonin3-like receptors.
    Ashby CR; Edwards E; Wang RY
    Synapse; 1992 Jan; 10(1):7-15. PubMed ID: 1536032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of intravenous diazepam on human lower oesophageal sphincter pressure under controlled double blind crossover conditions.
    Weihrauch TR; Förster CF; Köhler H; Ewe K; Krieglstein J
    Gut; 1979 Jan; 20(1):64-7. PubMed ID: 367884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship of serotonin-3 receptor antagonist activity to gastric emptying and motor-stimulating actions of prokinetic drugs in dogs.
    Gullikson GW; Loeffler RF; Viriña MA
    J Pharmacol Exp Ther; 1991 Jul; 258(1):103-10. PubMed ID: 2072288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.